Erich J. Conrad, MD
- 2Articles
- 9.9KReads1
- 2004–2011Active
- 7Collaborators
- 62Citations2
About
Erich J. Conrad, MD, has published research focused on treatment strategies for major depressive disorder (MDD), specifically investigating the use of pharmacologic augmentation agents. His work includes clinical trials assessing lamotrigine and various antipsychotics such as olanzapine, risperidone, quetiapine, and ziprasidone in patients with treatment-resistant depression. Conrad's publications appeared between 2004 and 2011 in Psychiatrist.com journals.
Publications
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
